Demetris Papamichael
Bank of Cyprus Oncology Center · 81 works · 8,582 citations · h-index 25
Top works
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
- Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
- Characteristics of Early-Onset vs Late-Onset Colorectal Cancer
- A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
- Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
- Is cancer biology different in older patients?
- Treatment of colorectal cancer in older patients
- Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer
- Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
- EORTC Elderly Task Force experts’ opinion for the treatment of colon cancer in older patients
- Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
- Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
- Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
- Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
- Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
- Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma
- Treatment of older patients with colorectal cancer: a perspective review